secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001854270-25-000073
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences stockholders elect three Class III directors and ratify KPMG as auditor
--------------------------------------------------------------------------------

- Brenda Cooperstone, James Collins, and Feng Hsiung elected as Class III directors to serve until 2028 annual meeting.
- Each director received over 17.3M votes for; broker non-votes ~1.2M per nominee.
- KPMG LLP ratified as independent auditor for FY2025 with 18,617,895 votes for, 13,519 against, 2,887 abstain.
- ~71% of outstanding shares (18.6M of 26.1M) represented at the virtual annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427025000073/0001854270-25-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427025000073/snti-20250625.htm
  HTML page:      https://secwatch.observer/filing/0001854270-25-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer